Description
Recombinant monoclonal antibody to CD8 beta. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YTS 156.7.7. This chimeric mouse antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques.
Target
CD8 beta
Target Alias Names
Lyt-3, T-cell surface glycoprotein CD8 beta chain, Lymphocyte antigen 3, T-cell membrane glycoprotein Ly-3, T-cell surface glycoprotein Lyt-3, CD8b, Cd8b, Cd8b1, Ly-3, Lyt-3, Lyt3
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression